CANadian CAnagliflozin REgistry: Patient-Reported Outcomes of Canagliflozin in the Treatment of Type 2 Diabetes Mellitus in Canadian Clinical Practice
ConclusionsTreatment with CANA is associated with improvements in satisfaction with body weight and overall health, which may be important drivers of patient self-management and hold the potential to positively influence long-term outcomes in T2DM.
Source: Canadian Journal of Diabetes - Category: Endocrinology Source Type: research
More News: Canada Health | Canagliflozin | Diabetes | Diabetes Mellitus | Diabetes Type 2 | Endocrinology | Invokana | Study | Weight Loss